1st Quarter - Amendment
SANDOZ INC for SANDOZ INC
Firm
Client
Income
—
Expenses
$890,000
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 20, 2026 | $140,000 | Replaced |
| 1st Quarter - Amendment (this page) | Jul 20, 2026 | $890,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Policies related to the ASP calculation in Medicare Part B Promoting a resilient pharmaceutical supply chain Policies related to serial patent litigation under the Hatch-Waxman Act. Issues related to increasing access to generic and biosimilar medications
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BARNARD | — |
| KATHLEEN CALLANAN New | Senior Legislative Assistant, Representative Mike Ross |
| JONATHAN KIMBALL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.